The intracranial injections of AAV encoding human PPT1 (hPPT1) increased enzyme activity and rescued phenotypic features of Batten disease in a mouse model of CLN1 disease (Ppt1−/−) [38]. The gene discussed is PPT1; the disease is juvenile neuronal ceroid lipofuscinosis.